OPRX
OptimizeRx CorpCompany with tickers: OPRX
CIK
1448431
CUSIP
68401U204
Shares Outstanding
18,765,075
Website
https://www.optimizerx.com
13F Activity (30d)
39 filings
38 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | — | ||||
| Net Income | — | ||||
| EPS (Basic) | — | ||||
| EPS (Diluted) | — |
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
By Product & Service (USD)
| Component | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Life Science Companies | $85,469,000 | $109,214,000 |
| Other Revenue | $6,658,000 | $215,000 |